Case Studies
Cracking HIV’s Code with AI-Designed Antibodies
ABS-101 Case Study: Potential best-in-class TL1A mAb for IBD
ABS-201 Case Study: Potential best-in-class antibody targeting the prolactin receptor for the treatment of androgenic alopecia
Blog Posts, Drug & Target Discovery, Science Blogs, Science content
Novel Target Discovery via Reverse Immunology
Blog Posts, Company News & Culture
Absci Appoints Professor Sir Mene Pangalos to its Board of Directors
